Screener
GoodRx Holdings, Inc. GDRX Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 90.8%-2.8pp | 91.8%-2.0pp | 92.8%-1.1pp | 93.5%-0.1pp | 93.7%+1.2pp | |
| Operating margin | 9.5%-1.6pp | 9.9%-0.3pp | 11%+2.7pp | 10.4%+6.6pp | 11.1%+14.9pp | |
| Net margin | 2.1%-2.3pp | 2.6%-1.0pp | 3.8%+1.8pp | 4%+6.0pp | 4.3%+11.9pp | |
| Returns | ||||||
| Return on equity | 2.5%-2.8pp | 3.2%-1.2pp | 4.5%+2.3pp | 4.9%+7.0pp | 5.3%+12.8pp | |
| Return on invested capital | 4.2%-2.1pp | 4.3%-1.4pp | 5.5%+1.3pp | 5.8%+2.2pp | 6.3%+9.7pp | |
| Efficiency | ||||||
| Asset turnover | 0.4×-0.1× | 0.5×-0.1× | 0.6×0.0× | 0.6×+0.1× | 0.6×+0.1× | |
| Liquidity | ||||||
| Current ratio | 1.4×-2.8× | 1.5×-3.8× | 2.6×-2.7× | 3.1×-2.4× | 4.2×-3.1× | |
| Leverage | ||||||
| Debt-to-equity | 0.8×0.0× | 0.9×0.0× | 0.9×+0.1× | 0.9×+0.1× | 0.9×-0.2× | |
| Net debt / EBITDA | 1.5×-0.1× | 1.9×+0.3× | 1.6×+0.9× | 1.7×+0.7× | 1.6×-0.7× | |
| Per Share | ||||||
| Book value per share | $1.86+3.3% | $1.82+5.7% | $1.73-6.6% | $1.73-3.7% | $1.80+3.5% | |
| Valuation | ||||||
| Market capitalization | $1.27B-18.1% | $671.45M-60.3% | $919.86M-48.1% | $1.47B-43.7% | $1.81B-40.5% | |
| Price / earnings | 78.1×+33.3× | 32.7×-26.8× | 30.2×-77.9× | 46.3×— | 52.3×— | |
| Price / sales | 1.6×-0.3× | 0.9×-1.3× | 1.2×-1.1× | 1.8×-1.5× | 2.3×-1.7× | |
| Price / book | 2×-0.5× | 1.1×-1.5× | 1.5×-1.0× | 2.4×-1.3× | 2.8×-1.7× | |
| EV / EBITDA | 9.2×-1.7× | 5.9×-6.4× | 7×-6.8× | 10.6×-11.5× | 12.5×-27.7× |
FAQ
- What are GoodRx Holdings, Inc.'s profit margins?
- GoodRx Holdings, Inc. (GDRX) runs a 90.8% gross margin and a 9.5% operating margin, with a 2.1% net margin.
- Where do GoodRx Holdings, Inc.'s ratios come from?
- Every ratio is computed from GoodRx Holdings, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
